Ringoes, NJ, United States of America

Avinash Desai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avinash Desai. Retrieved from https://idiyas.com/inventor/avinash-desai-066kii69

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Avinash Desai: Innovator in Cancer Treatment

Introduction

Avinash Desai is a notable inventor based in Ringoes, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative work. His dedication to advancing medical science is evident in his patent portfolio.

Latest Patents

Avinash holds a patent titled "Radioconjugates Targeting CD33 in the Treatment of Sarcomas." This patent represents a crucial step in developing targeted therapies for cancer, specifically sarcomas, which are a type of cancer that arises from connective tissues.

Career Highlights

Avinash is currently employed at Actinium Pharmaceuticals, Limited, where he continues to work on groundbreaking treatments. His role at the company allows him to collaborate with other experts in the field and contribute to the development of innovative therapies.

Collaborations

One of his notable coworkers is Mary M Chen. Together, they work towards advancing cancer treatment options and improving patient outcomes.

Conclusion

Avinash Desai's contributions to cancer treatment through his patent and work at Actinium Pharmaceuticals, Limited highlight his commitment to innovation in the medical field. His efforts are paving the way for more effective therapies for patients battling sarcomas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…